Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.
复制标题
移植后淋巴细胞增殖性疾病患者中 Epstein-Barr 病毒感染的 B 细胞的特征：利妥昔单抗治疗后消失并不能预测临床反应。
作者：
Yang,J;Tao,Q;Flinn,IW;Murray,PG;Post,LE;Ma,H;Piantadosi,S;Caligiuri,MA;Ambinder,RF
